Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Other Working Capital Changes: 2010-2025

Historic Other Working Capital Changes for Arrowhead Pharmaceuticals (ARWR) over the last 16 years, with Sep 2025 value amounting to $9.9 million.

  • Arrowhead Pharmaceuticals' Other Working Capital Changes fell 695.12% to -$13.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year increase of 343.71%. This contributed to the annual value of $9.9 million for FY2025, which is 343.71% up from last year.
  • According to the latest figures from FY2025, Arrowhead Pharmaceuticals' Other Working Capital Changes is $9.9 million, which was up 343.71% from $2.2 million recorded in FY2024.
  • Arrowhead Pharmaceuticals' Other Working Capital Changes' 5-year high stood at $9.9 million during FY2025, with a 5-year trough of -$129.2 million in FY2023.
  • Over the past 3 years, Arrowhead Pharmaceuticals' median Other Working Capital Changes value was $2.2 million (recorded in 2024), while the average stood at -$39.0 million.
  • In the last 5 years, Arrowhead Pharmaceuticals' Other Working Capital Changes slumped by 51,748.61% in 2022 and then soared by 343.71% in 2025.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Other Working Capital Changes (Yearly) stood at $217,820 in 2021, then slumped by 51,748.61% to -$112.5 million in 2022, then dropped by 14.83% to -$129.2 million in 2023, then soared by 101.73% to $2.2 million in 2024, then soared by 343.71% to $9.9 million in 2025.